Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Colorcon
Dow

Last Updated: August 9, 2022

MICONAZOLE NITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Miconazole Nitrate patents expire, and when can generic versions of Miconazole Nitrate launch?

Miconazole Nitrate is a drug marketed by Perrigo R And D, Cosette, Perrigo, Taro Pharms, Teva, Teva Pharms, Actavis Pharma, P And L, and L Perrigo Co. and is included in twelve NDAs.

The generic ingredient in MICONAZOLE NITRATE is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Miconazole Nitrate

A generic version of MICONAZOLE NITRATE was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.

  Try it Free

Drug patent expirations by year for MICONAZOLE NITRATE
Drug Prices for MICONAZOLE NITRATE

See drug prices for MICONAZOLE NITRATE

Drug Sales Revenue Trends for MICONAZOLE NITRATE

See drug sales revenues for MICONAZOLE NITRATE

US Patents and Regulatory Information for MICONAZOLE NITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D MICONAZOLE NITRATE miconazole nitrate CREAM, INSERT;TOPICAL, VAGINAL 079114-001 Jun 2, 2010 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva Pharms MICONAZOLE NITRATE miconazole nitrate CREAM;VAGINAL 074030-001 Oct 30, 1992 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Perrigo R And D MICONAZOLE NITRATE miconazole nitrate CREAM;VAGINAL 091366-001 Jan 15, 2010 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
McKinsey
Colorcon
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.